Ken Inoue1, 10, 11, Mehrdad Khajavi1, 11, Tomoko Ohyama1, Shin-ichi Hirabayashi2, John Wilson3, James D Reggin4, Pedro Mancias5, Ian J Butler5, Miles F Wilkinson6, Michael Wegner7
& James R Lupski1, 8, 91
Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Room 604B, Houston, Texas 77030, USA.
2
Division of Pediatric Neurology, Nagano Children's Hospital, Nagano, Japan.
3
Department of Neurology, Great Ormond Street Children's Hospital, London, UK.
4
Meritcare Neuroscience Clinic, Fargo, North Dakota, USA.
5
Department of Neurology, The University of Texas Medical School at Houston, Houston, Texas, USA.
6
Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
7
Institut für Biochemie, Universität Erlangen-Nürnberg, Erlangen, Germany.
8
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
9
Texas Children's Hospital, Houston, Texas, USA.
10
Present address: Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.
11
These authors contributed equally to this work.
Correspondence should be addressed to James R Lupski jlupski@bcm.tmc.edu
